RxDoctor Payments Data

Annette Shon

Family · Los Angeles, CANPI 1043593064

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $362,777 of the $406,460 with a category attached, or 89.3%. AbbVie accounts for 99.9% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2023 at $196,243 and has fallen 99.9% since, to $162 in 2025. Among family clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$406,460in general payments, 2019–2025

Across 521 payments — averaging $780.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$406K
  • Galderma Laboratories, L.p.$388
  • Revance Therapeutics, Inc.$91
  • Merz North America, Inc.$47

What the payments were for

  • Speaking & faculty fees$362,77789%
  • Travel & lodging$33,6748%
  • Food & beverage$10,0012%
  • Education$80%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)499$405,934
Galderma Laboratories, L.p.17$388
Revance Therapeutics, Inc.4$91
Merz North America, Inc.1$47

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$406,460 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.

See all family providers in California →

Other family in Los Angeles

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →